Physician profile
Joerg Albrecht
NPI 1942453022
$3,556.66
in general payments reported to CMS, 2019-2025
5 companies · $3,222 in 2025
The $3,222 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.19 · 2021: $105 · 2022: $204 · 2025: $3,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,222.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $3,222.00 | 2025 | |
| Kerecis Limited | $204.30 | 2022 | |
| Galderma Laboratories, L.P. | $105.17 | 2021 | |
| Amgen INC. | $25.19 | 2020 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joerg Albrecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.